Role of Probiotics and Gut microbiota in Liver Diseases

Author:

Beevi S S Safeena1,Pottakkat Biju2,Narayanan Sankar2

Affiliation:

1. Associate Professor, College of Nursing, JNMC, Aligarh Muslim University, Uttar Pradesh, India.

2. Professor, Department of Surgical Gastroenterology, JIPMER, Puducherry, India.

Abstract

The complex combination of numerous microbes present in the GI tract of human being is referred to as Gut microbiota, consists of almost 1000 microbial cells, that is almost many times higher than that of human tissues in a person. The intestinal microbiota in each person has a completely unique blend of species. Trillions of microbes are present in the human body which include both beneficial and dangerous organisms. The microbiota plays a crucial role in nutritional status, immune level and effects on the behaviour and cognitive development. The human gastrointestinal tract has many bacterial species, provides a microbial barrier in opposition to potential pathogens and it regulates the frame's immune responses. The gut microbiota composition has a major function in the occurrence of liver illnesses. Variations within the gut microbiota seem to have an important position in the pathogenesis and progression of many gastrointestinal and liver sicknesses. Alterations within the features of liver-intestine axis can cause release of pro-inflammatory cytokines and autoimmune responses inside the liver which can have deleterious impact on liver cells. Administration of health enhancing microbes may ameliorate dangerous interactions and hepatic disorders. This review addresses the role of intestine microbiota in hepatic diseases and the impact of probiotics in the management of hepatic diseases.

Publisher

A and V Publications

Subject

General Medicine

Reference57 articles.

1. FAO/WHO, Guidelines for the evaluation of probiotics in food 2006.

2. Experimental Biology 2018. "Growing evidence that probiotics are good for your liver: In mice, probiotic treatment shown to protect against liver damage from acetaminophen." Science Daily. 23 April 2018. .

3. Backhed F. Programming of host metabolism by the gut microbiota. Ann NutrMetab 2011: 58: 44-52.

4. Bellot P, Frances R, Such J. Pathological bacterial translocation in cirrhosis; pathophysiology, diagnosis and clinical implications. Liver Int 2013; 33: 31-39

5. Nitin J, Mithun S, Rao PN, Nageshwar Reddy D. Liver Diseases: The Role of Gut Microbiota and Probiotics. J Prob Health 2016; 4: 154-62. doi: 10.4172/2329-8901.1000154.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3